YKVPQL | αs1-CN | 119–124 | ACE-inhibitory | Maeno et al. (1996) |
LPP | β-CN | 166–168 | ACE-inhibitory | Norris et al. (2014) |
VP | β-CN | 23–24, 99–100, 188–189, 193–194 | ACE-inhibitory | Norris et al. (2014) |
IR | β-LG | 163–164 | ACE-inhibitory | Murakami et al. (2004) |
LL | β-LG | 4–5, 47–48, 73–74, 119–120 | ACE-inhibitory | Pan et al. (2012) |
IPP | κ-CN | 129–131 | Antioxidant | Chakrabarti et al. (2017) |
Anti-inflammatory | Adams et al. (2020) |
ACE-inhibitory | Jing et al. (2014) |
VSP | κ-CN Genetic Variant F1 | 169–171 | ACE-inhibitory | Weimann et al. (2009) |